Literature DB >> 28291714

Analysis of the RENAL and mRENAL Scores and the Relative Importance of Their Components in the Prediction of Complications and Local Progression after Percutaneous Renal Cryoablation.

Samdeep K Mouli1, Joseph L McDevitt2, Yu-Kai Su1, Ann B Ragin1, Yi Gao3, Albert A Nemcek1, Robert J Lewandowski1, Riad Salem1, Kent T Sato1.   

Abstract

PURPOSE: To determine if modified RENAL (mRENAL) score and its individual components have superior predictive value relative to the RENAL nephrometry score in prediction of complications and recurrence after percutaneous renal cryoablation.
MATERIALS AND METHODS: Primary masses treated with CT-guided percutaneous renal cryoablation between June 2007 and May 2016 were retrospectively reviewed. RENAL and mRENAL scores were used to stratify masses into low, medium, and high complexity tertiles. Complications were characterized by SIR criteria. Predictors of complications and local progression were analyzed using multivariate logistic regression and Kaplan-Meier analysis.
RESULTS: There were 95 renal cryoablation procedures in 86 patients. Of ablations, 89 had at least 1 follow-up imaging study, with median follow-up of 29 months. There were 11 (12.4%) complications, including 5 (6.5%) major complications. Mass complexity, as measured by mRENAL complexity tertile, was associated with increased risk of complications on multivariate analysis (P = .045). Endophytic location was the only individual ordinal component of the RENAL and mRENAL scores associated with complications (P = .021). Local progression occurred in 7 (8.3%) masses. Complexity as measured by either scoring system was not associated with local progression. Only diameter > 3 cm was associated with increased risk of local progression (hazard ratio = 9.9, 95% confidence interval = 2.1-45, P = .003).
CONCLUSIONS: mRENAL score was predictive of complications and tumor size was predictive of recurrence. Use of mRENAL score for complications and tumor size for recurrence should allow for simpler risk stratification and more accurate patient counseling.
Copyright © 2016 SIR. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28291714     DOI: 10.1016/j.jvir.2016.12.1224

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  4 in total

Review 1.  Pneumodissection during Percutaneous Renal Ablation Resulting in Air Embolism: Percutaneous Management and a Review of the Literature.

Authors:  Kamil Arif; Andrew J Gunn
Journal:  Semin Intervent Radiol       Date:  2019-05-22       Impact factor: 1.513

2.  Safety and efficacy of RFA versus MWA for T1a renal cell carcinoma: a propensity score analysis.

Authors:  Brigit M Aarts; Fernando M Gomez; Marta Lopez-Yurda; Rob F M Bevers; Joris Herndriks; Regina G H Beets-Tan; Axel Bex; Elisabeth G Klompenhouwer; Rutger W van der Meer
Journal:  Eur Radiol       Date:  2022-09-06       Impact factor: 7.034

3.  Trans-Arterial Embolization of Renal Cell Carcinoma prior to Percutaneous Ablation: Technical Aspects, Institutional Experience, and Brief Review of the Literature.

Authors:  Andrew J Gunn; Benjamin J Mullenbach; May M Poundstone; Jennifer B Gordetsky; Edgar S Underwood; Soroush Rais-Bahrami
Journal:  Curr Urol       Date:  2018-06-30

4.  Percutaneous Microwave Ablation of Histologically Proven T1 Renal Cell Carcinoma.

Authors:  B M Aarts; W Prevoo; M A J Meier; A Bex; R G H Beets-Tan; E G Klompenhouwer; F M Gómez
Journal:  Cardiovasc Intervent Radiol       Date:  2020-02-12       Impact factor: 2.740

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.